Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine

@article{Silberstein2018HealthCR,
  title={Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine},
  author={Stephen D. Silberstein and Lulu Lee and Kavita Gandhi and Timothy P. Fitzgerald and Jvawnna D Bell and Joshua M. Cohen},
  journal={Headache: The Journal of Head and Face Pain},
  year={2018},
  volume={58}
}
  • S. Silberstein, L. Lee, +3 authors Joshua M. Cohen
  • Published 30 October 2018
  • Medicine
  • Headache: The Journal of Head and Face Pain
To examine the disability, health care resource utilization, and direct annual costs among patients with migraine, categorized according to the number of headache days experienced in the past month. 
Episodic and Chronic Migraine in Primary Care
To inform migraine care model development by assessing differences between patients with chronic migraine (CM) and episodic migraine (EM) in the current state of treatment, disability, patientExpand
Impact of emergency department opioid use on future health resource utilization among patients with migraine
The purpose of this study was to evaluate the subsequent health resource utilization (HRU) between patients with migraine who received opioid medications at their emergency department (ED) visitsExpand
Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
TLDR
Characterizing more narrow headache day frequency groups may be of value for better understanding the broad range of migraine experience and making treatment decisions. Expand
Estimating the savings associated with a migraine‐free life: results from the Spanish Atlas
TLDR
The aims of this study were to quantify the costs of chronic and episodic migraine in Spain, evaluating the impact of psychiatric comorbidities and disability, and to estimate the economic savings associated with reducing the number of migraine‐days by 50%. Expand
Management of Childhood Migraine by Headache Specialist vs Non‐Headache Specialists
TLDR
The use of appropriate rescue medications and prophylactic agents, application of neuroimaging, and short‐term outcomes are compared in children treated by the two groups of physicians. Expand
Behavioral Therapy Preferences in People With Migraine
There are safe and well‐tolerated level A evidence‐based behavioral therapies for the prevention of migraine. They are biofeedback, cognitive behavioral therapy, and relaxation. However, theExpand
Migraine: Epidemiology, Burden, and Comorbidity.
TLDR
Chronic migraine is the second most disabling condition worldwide and is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life. Expand
Systematic review of outcomes and endpoints in preventive migraine clinical trials
TLDR
Over the last six decades, clinical trials of migraine preventive treatments have led to the regulatory approval of many medications and devices, but the outcomes and endpoints used in these trials are broad and not well standardized. Expand
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care
TLDR
Migraine burden increased by each failed treatment line and was associated with increasedComorbidity, and migraine patients had significantly higher extent of visits and sick-leave days as well as extent of comorbidities when compared to their age- and gender-matched counterparts. Expand
Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe
TLDR
There is a need for more effective treatments that can reduce migraine frequency and thus improve HRQoL, increase work productivity, and reduce both activity impairment and HRU in patients suffering from migraine. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 42 REFERENCES
Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study
Background.— Though symptomatic medication overuse is believed to play a major role in progression from episodic to chronic or transformed migraine (TM), population‐based longitudinal data on theseExpand
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS‐II)
TLDR
The objective was to characterize patterns of preventive medication use in persons with episodic migraine (EM) and chronic migraine (CM) and to establish a baseline level of trust in the use of these medications. Expand
Similarities and Differences Between Chronic Migraine and Episodic Migraine
Objective.—To quantify and characterize the similarities and the differences between chronic migraine (CM) patients with medication overuse and episodic migraine (EM) patients with only occasionalExpand
Frequency and Burden of Headache‐Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study
While nausea is a defining feature of migraine, the association of nausea with other headache features and its influence on the burden of migraine have not been quantified. Population‐based data wereExpand
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
TLDR
Comparing episodic to chronic migraine sufferers to determine if migraine status predicted headache-related disability, health-related quality of life (HRQoL) and health care resource utilization provides evidence that will enhance understanding of the factors driving health care costs and will contribute to development of cost-effective health care strategies. Expand
Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study
TLDR
Direct costs of migraine increase with increasing frequency of migraine-associated nausea, and both frequency and severity of headache-related nausea should be monitored as part of ongoing care of persons with migraine. Expand
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.
TLDR
A PubMed literature search was conducted for studies on the impact of migraine, including disability, health-related quality of life (HRQoL), comorbidities, and instruments used by health care professionals to treat patients with migraine. Expand
Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results
TLDR
Persistent frequent headache‐related nausea (PFN) in persons with episodic migraine (EM) as a predictor of new onset chronic migraine (CM) is evaluated. Expand
Considerations for management of migraine symptoms in the primary care setting
TLDR
An overview of the prevalence, symptoms, burden, and diagnosis of migraine with a focus on adults is provided and insight is provided into factors for consideration when prescribing acute/abortive treatment for migraine to ensure that individual patients receive optimal pharmaceutical management. Expand
Prophylaxis of migraine
TLDR
The issues that guide the decision-making process in migraine preventive treatment are discussed, including the specific prophylactic approach needs to be individualized taking into account multiple variables. Expand
...
1
2
3
4
5
...